Page last updated: 2024-10-28

ifosfamide and Fibrosis

ifosfamide has been researched along with Fibrosis in 2 studies

Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.

Research Excerpts

ExcerptRelevanceReference
"The efficacy of zoledronic acid (ZOL), with or without the anticancer drug ifosfamide (IFO), was tested on primary bone tumor growth using a rat-transplantable model of osteosarcoma."7.73Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma. ( Blanchard, F; Charrier, C; Coipeau, P; Couillaud, S; Gouin, F; Heymann, D; Heymann, MF; Ory, B; Redini, F; Thiery, JP, 2005)
"The efficacy of zoledronic acid (ZOL), with or without the anticancer drug ifosfamide (IFO), was tested on primary bone tumor growth using a rat-transplantable model of osteosarcoma."3.73Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma. ( Blanchard, F; Charrier, C; Coipeau, P; Couillaud, S; Gouin, F; Heymann, D; Heymann, MF; Ory, B; Redini, F; Thiery, JP, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heymann, D1
Ory, B1
Blanchard, F1
Heymann, MF1
Coipeau, P1
Charrier, C1
Couillaud, S1
Thiery, JP1
Gouin, F1
Redini, F1
Friedlaender, MM1
Haviv, YS1
Rosenmann, E1
Peylan-Ramu, N1

Other Studies

2 other studies available for ifosfamide and Fibrosis

ArticleYear
Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma.
    Bone, 2005, Volume: 37, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Remodeling; Caspases; Cell Line, Tumor

2005
End-stage renal interstitial fibrosis in an adult ten years after ifosfamide therapy.
    American journal of nephrology, 1998, Volume: 18, Issue:2

    Topics: Adult; Antineoplastic Agents, Alkylating; Fibrosis; Humans; Ifosfamide; Kidney; Kidney Failure, Chro

1998